rare oncology drugs - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

Palantir Technologies (NASDAQ: PLTR) expands Asia enterprise push through LG CNS partnership

What LG CNS and Palantir’s new partnership means for the future of industrial AI adoption

Representative image of the United States Strategic Petroleum Reserve and oil infrastructure as the Trump administration authorises a 172 million barrel SPR drawdown while 32 International Energy Agency nations coordinate the largest emergency oil release in history to stabilise global crude markets.

Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release

IBM Corporation and Lam Research Corporation launch five-year collaboration to enable sub-1nm semiconductor logic scaling

The sub-1nm race is heating up and IBM and Lam Research just made their move

Representative image showing an oil tanker under attack in the Strait of Hormuz as tensions involving Iran’s Islamic Revolutionary Guard Corps raise fears of a major supply disruption that analysts warn could push global oil prices toward $200 per barrel.

Iran: Get ready for $200 oil. IRGC fires on more ships in the Gulf

Read More

4 minute read

Pharma Industry News

ESTEVE acquires Caprelsa from Sanofi to boost rare cancer drug portfolio and global specialty focus

ESTEVE is acquiring Caprelsa® from Sanofi to expand its rare cancer drug portfolio. The deal boosts ESTEVE's focus on highly specialized treatments.

byPallavi Madhiraju

July 2, 2025

web analytics